Sabah Oney

Co-Founder, Interim CEO, Member Board of Directors, Vilya

Venture Partner at ARCH Venture Partners

San Francisco Bay Area, California

About

Male

Sabah Oney is a Venture Partner at ARCH Venture Partners. He attended Stanford University Graduate School of Business, Duke University, and the University of Kansas.

Experience

ARCH Venture Partners

Venture Partner · 2021 – present

View →

31Chicago, Illinois, United StatesFinance · Financial Services

Co-Founder, Interim CEO, Member Board of Directors · Vilya
2022 – present
Board Member · Dispatch Bio

Education

Duke University · Doctor of Philosophy - PhD, Genetics and Genomics
2003 – 2008
University of Kansas · B.S., Genetics
1999 – 2003

Headlines from Google News. Social posts load from the platform only when you open a tab.

Sabah Öney joins Fred Hutch Board of Directors
Fred Hutchinson Cancer Center · Jan 12
CAR-T Cells Against Solid Tumors: Sabah Oney on The Long Run
Timmerman Report · Aug 6
The story behind Dispatch Biotherapeutics, an immunotherapy start-up with Penn roots
Inquirer.com · Jul 28
Dispatch Bio Launches to Deliver Universal Treatment Across Solid Tumors with Novel Immunotherapy Approach
BioSpace · Jul 23
Cancer biotech Dispatch unveils with $216M and CAR-T pioneer Carl June as cofounder
fiercebiotech.com · Jul 23

People at ARCH Venture Partners

Data from: crunchbase